MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mpg.0b013e31829ce5cd

Медицинская библиотека · Journal of pediatric gastroenterology and nutrition · 2013

Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease.

Zitomersky Naamah L, Levine Anne E, Atkinson Benjamin J, Harney Kathy M, Verhave Menno, Bousvaros Athos, Lightdale Jenifer R, Trenor Cameron C

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Pediatric inpatients with inflammatory bowel disease (IBD) are rarely considered for thromboprophylaxis because of concerns about safety and underappreciation of thrombotic risk. We characterized thromboembolism (TE) in children and young adults with inflammatory bowel disease (IBD) at a single tertiary care hospital.

METHODS

We performed a retrospective review of an inpatient billing database for all IBD admissions with colonic involvement and an anticoagulation database for thrombotic complications from 2006 to 2011.

RESULTS

Of 532 patients admitted with IBD with colonic involvement, 10 (1.9%) had TE (9 venous, 1 arterial), 2 of whom had recurrent thrombosis. Many of the events resulted in considerable morbidity, including 4 cerebrovascular events and 2 pulmonary emboli. Established risk factors in IBD colitis inpatients with TE included: indwelling catheter (4/10), first-degree family member with TE (2/10), hereditary thrombophilia (3/10), smoking (1/10), oral contraceptive (1/5 females), and thalidomide (1/10). Additionally, most (8/10) patients had acquired thrombophilia, mostly elevation of factor VIII and anticardiolipin antibodies. Patients with IBD and TE received therapeutic anticoagulation without significantly increased bleeding. Thrombus resolution was documented in 7 cases, persistence in 2 cases and recurrence in 2 cases.

CONCLUSIONS

Pediatric inpatients hospitalized with IBD with colonic involvement have increased risk of TE, including complications of pulmonary embolism, recurrence, persistence, and indefinite long-term anticoagulation. Therapeutic anticoagulation in patients with IBD with active colitis appears safe. We identified both inherited thrombophilias and acquired risk factors in patients with IBD and TE. We presently use risk stratification and recommend prophylactic anticoagulation in high-risk patients.

Для цитирования: Zitomersky Naamah L, Levine Anne E, Atkinson Benjamin J, Harney Kathy M, Verhave Menno, Bousvaros Athos, Lightdale Jenifer R, Trenor Cameron C. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease.. Journal of pediatric gastroenterology and nutrition. 2013. DOI: 10.1097/mpg.0b013e31829ce5cd.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.